Abstract:Antimicrobial photodynamic therapy (aPDT) effectively treats multidrug-resistant bacterial infections by utilizing photosensitizers to generate cytotoxic reactive oxygen species. Exploiting fluorescence resonance energy transfer (FRET) effect shows great potential for enhancing the efficacy of aPDT. Typically, this method involves encapsulating fluorescent molecules, including photosensitizers, into nanomaterials or coadsorbing them onto materials. Here, we develop a strategy that directly utilizes bacteria as carriers to bring two types of photosensitizers together to induce the FRET. We designed an aggregation-induced emission (AIE) photosensitizer ( CPVBP3 ) and an aggregation-caused quenching (ACQ) photosensitizer ( TPP3 ), both featuring the same bacterial membrane-targeting group to direct them to bacteria. Under white light exposure (12 J/cm 2 ), the bactericidal effect of the combination of CPVBP3 and TPP3 at 5 μM each on Escherichia coli (4.7 log10) was much stronger than their individual use at 5 or 10 μM, highlighting synergistic antibacterial action. In Escherichia coli , TPP3 absorbed the fluorescence of CPVBP3 , reducing its lifetime from 0.98 ns to 0.74 ns, confirming the occurrence of FRET. This combination also demonstrated a significantly stronger synergistic aPDT effect on Acinetobacter baumannii . Moreover, CPVBP3 synergized with methylene blue against Escherichia coli , indicating the universality of this strategy. Additionally, the efficacy and biosafety of this therapeutic approach were validated in a mouse wound model infected with Escherichia coli . In summary, this FRET strategy overcomes the limitations associated with the need for pre-binding photosensitizers with materials and the challenge of these mixtures penetrating bacteria (for greater damage), ultimately opening new avenues for further enhancing the efficacy of aPDT.

A Facile and Light-Controllable Drug Combination for Enhanced Photopharmacology

Engineering the novel azobenzene-based molecular photoswitches for suppressing bacterial infection through dynamic regulation of biofilm formation

Photoisomerization and light‐controlled antibacterial activity of fluoroquinolone‐azoisoxazole hybrids

β-Lactamase-Responsive Probe for Efficient Photodynamic Therapy of Drug-Resistant Bacterial Infection

AIE-Active Antibiotic Photosensitizer with Enhanced Fluorescence in Bacteria Infected Cells and Better Therapy Effect Toward Drug-Resistant Bacteria

A visible light-activated azo-fluorescent switch for imaging-guided and light-controlled release of antimycotics

Light-activated Nanocatalyst for Precise In-situ Antimicrobial Synthesis via Photoredox-Catalytic Click Reaction

In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial Chemotherapy

Light-Responsive Smart Nanoliposomes: Harnessing the Azobenzene Moiety for Controlled Drug Release under Near-Infrared Irradiation

Direct growth control of antibiotic‐resistant bacteria using visible‐light‐responsive novel photoswitchable antibiotics

Photoswitchable Azobenzene/Cyclodextrin Host‐Guest Complexes: from UV‐ to Visible/Near‐IR‐Light‐Responsive Systems

Zinc(II)-Tetradentate-Coordinated Probe with Aggregation-Induced Emission Characteristics for Selective Imaging and Photoinactivation of Bacteria.

Light-Activable Inhibitor Overcomes Antimicrobial Resistance and Regulates Antibacterial Activity

Bacterial-mediated FRET between AIE and ACQ photosensitizers for enhanced antimicrobial photodynamic therapy

Bacterial Infection Microenvironment Sensitive Prodrug Micelles with Enhanced Photodynamic Activities for Infection Control

Novel photoactivated Indole–pyridine chemotherapeutics with strong antimicrobial and antibiofilm activity toward Staphylococcus aureus

Surface Charge Switchable Antibiotics Based Small Molecular Micelles Combined with Photodynamic Therapy for Antibacterial and Antibiofilm Applications

Aggregation-Induced Emission Photosensitizer with Ag(I)-π Interaction-Enhanced Reactive Oxygen Species for Eliminating Multidrug Resistant Bacteria

Cationic AIE-active photosensitizers for highly efficient photodynamic eradication of drug-resistant bacteria

Blue light-mediated gene expression as a promising strategy to reduce antibiotic resistance in Escherichia coli

The Commercial Antibiotics with Inherent Aggregation-Induced Emission Characteristics